These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 288583)

  • 21. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
    Kitagawa M; Matsubara O; Kasuga T
    Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spleen in Friend leukemia. I. Prolonged survival of leukemic mice after autoimplantation of spleen tissue.
    Levy SB; Rubenstein CB; Friend C
    J Natl Cancer Inst; 1976 Jun; 56(6):1183-8. PubMed ID: 1069138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.
    Genovesi EV; Marx PA; Wheelock EF
    J Exp Med; 1977 Aug; 146(2):520-34. PubMed ID: 327016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.
    Risser R
    J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H-2D (Rfv-1) gene influence on recovery from Friend virus leukemia is mediated by nonleukemic cells of the spleen and bone marrow.
    Britt WJ; Chesebro B
    J Exp Med; 1980 Dec; 152(6):1795-804. PubMed ID: 6935387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis.
    Gillis S; Gillis AE; Smith KA
    J Exp Med; 1978 Jul; 148(1):18-31. PubMed ID: 78957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors from lymphoid cell tumor affecting immune responses.
    Specter S; Schneider R; Friedman H
    Ann N Y Acad Sci; 1979; 332():531-8. PubMed ID: 394642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered interleukin production during Friend leukemia virus infection.
    Lopez-Cepero M; Specter S; Matteucci D; Friedman H; Bendinelli M
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):353-63. PubMed ID: 3293056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.
    Chesebro B; Wehrly K; Doig D; Nishio J
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5784-8. PubMed ID: 293683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of genetic resistance to Friend virus leukemia in mice. II. Resistance of mitogen-responsive lymphocytes mediated by marrow-dependent cells.
    Kumar V; Bennett M
    J Exp Med; 1976 Apr; 143(4):713-27. PubMed ID: 176309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous regression of Friend virus-induced erythroleukemia. II. regression of Friend murine leukemia virus-induced lymphocytic leukemia.
    Dietz M; Longley C; Fouchey SP; Hall L; Rich MA; Furmanski P
    J Natl Cancer Inst; 1977 Sep; 59(3):957-61. PubMed ID: 197250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunotherapy of Friend leukemia with antiserum (author's transl)].
    Lynn TC; Metzgar RS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):94-104. PubMed ID: 7449527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Livnat D; Collins JJ
    Leuk Res; 1982; 6(4):577-93. PubMed ID: 6958931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous regression in virus-induced murine leukemia. I. Host-virus system.
    Rich MA; Siegler R; Karl S; Clymer R
    J Natl Cancer Inst; 1969 Apr; 42(4):559-69. PubMed ID: 5251782
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of host mechanisms involved in suppression of established Friend virus leukemia.
    Wheelock EF
    Bibl Haematol; 1975 Oct; (43):508-10. PubMed ID: 1067088
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-toxic endotoxin polysaccharide induces soluble mediators which potentiate antibody production by murine retrovirus-suppressed splenocytes.
    Friedman H; Butler RC; Specter S; Nowotny A
    Int J Immunopharmacol; 1988; 10(3):283-92. PubMed ID: 3053470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
    DiCicco LM; Truitt GA; Wheelock EF
    Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Origin of spleen colonies generated by Friend virus-infected cells in mice.
    Steeves RA; Bubbers JE; Plata F; Lilly F
    Cancer Res; 1978 Sep; 38(9):2729-33. PubMed ID: 679178
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of antibody response helper factors in immunosuppressive effects of friend leukemia virus.
    Butler RC; Frier JM; Chapekar MS; Graham MO; Friedman H
    Infect Immun; 1983 Mar; 39(3):1260-4. PubMed ID: 6220970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.